WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 46 filers reported holding WEREWOLF THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,278,318 | -29.7% | 1,531,924 | +0.1% | 0.00% | – |
| Q2 2023 | $4,666,058 | +17.2% | 1,529,855 | -0.1% | 0.00% | – |
| Q1 2023 | $3,981,804 | +26.7% | 1,531,463 | -0.1% | 0.00% | – |
| Q4 2022 | $3,143,864 | +20859.1% | 1,533,592 | +43994.1% | 0.00% | – |
| Q3 2022 | $15,000 | +36.4% | 3,478 | +29.1% | 0.00% | – |
| Q2 2022 | $11,000 | -88.8% | 2,694 | -87.9% | 0.00% | – |
| Q1 2022 | $98,000 | -70.9% | 22,317 | -21.0% | 0.00% | – |
| Q4 2021 | $337,000 | +2963.6% | 28,265 | +4466.2% | 0.00% | – |
| Q3 2021 | $11,000 | +37.5% | 619 | +27.1% | 0.00% | – |
| Q2 2021 | $8,000 | – | 487 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,531,665 | 35.68% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $11,138,847 | 4.64% |
| MPM BioImpact LLC | 2,388,011 | $6,208,829 | 1.61% |
| RA Capital Management | 6,144,881 | $15,976,691 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,629,706 | 0.27% |
| PFM Health Sciences, LP | 2,217,220 | $5,764,772 | 0.26% |
| Rubric Capital Management LP | 1,935,357 | $5,031,928 | 0.13% |
| Laurion Capital Management LP | 522,900 | $1,359,540 | 0.01% |
| Alyeska Investment Group, L.P. | 397,808 | $1,034,301 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 81,711 | $212,449 | 0.01% |